DE69931644D1 - Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen - Google Patents

Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen

Info

Publication number
DE69931644D1
DE69931644D1 DE69931644T DE69931644T DE69931644D1 DE 69931644 D1 DE69931644 D1 DE 69931644D1 DE 69931644 T DE69931644 T DE 69931644T DE 69931644 T DE69931644 T DE 69931644T DE 69931644 D1 DE69931644 D1 DE 69931644D1
Authority
DE
Germany
Prior art keywords
diagnosis
presentation
classification
determination
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69931644T
Other languages
English (en)
Other versions
DE69931644T2 (de
Inventor
M Ali
Robert Cafferkey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Application granted granted Critical
Publication of DE69931644D1 publication Critical patent/DE69931644D1/de
Publication of DE69931644T2 publication Critical patent/DE69931644T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69931644T 1998-09-23 1999-09-23 Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen Expired - Fee Related DE69931644T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10152298P 1998-09-23 1998-09-23
US101522P 1998-09-23
PCT/US1999/021774 WO2000016805A1 (en) 1998-09-23 1999-09-23 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer

Publications (2)

Publication Number Publication Date
DE69931644D1 true DE69931644D1 (de) 2006-07-06
DE69931644T2 DE69931644T2 (de) 2007-05-10

Family

ID=22285082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931644T Expired - Fee Related DE69931644T2 (de) 1998-09-23 1999-09-23 Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen

Country Status (7)

Country Link
EP (1) EP1115426B1 (de)
JP (1) JP2002526055A (de)
AT (1) ATE327766T1 (de)
CA (1) CA2343918A1 (de)
DE (1) DE69931644T2 (de)
ES (1) ES2267291T3 (de)
WO (1) WO2000016805A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
CA2530605A1 (en) * 2003-06-27 2005-05-26 Diadexus, Inc. Pro104 antibody compositions and methods of use
WO2005010180A1 (ja) * 2003-07-23 2005-02-03 Hokkaido Technology Licensing Office Co., Ltd. ホメオボックス遺伝子の発現による癌の判定方法
AU2004303448A1 (en) * 2003-12-23 2005-07-07 Mount Sinai Hospital Methods for detecting markers associated with endometrial disease or phase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736377A (en) * 1995-06-06 1998-04-07 New England Medical Center Hospitals, Inc. NES-1 polypeptides, DNA, and related molecules and methods
US6479274B1 (en) * 1997-02-13 2002-11-12 Amrad Operations Pty., Ltd. DNA molecules encoding human HELA2 or testisin serine proteinases
EP1105528A4 (de) * 1998-08-04 2002-09-04 Diadexus Inc Verfahren zur diagnose, überwachung, klassifizierung, bildgebungund behandlung von brustkrebs
PT1109937E (pt) * 1998-09-02 2009-02-10 Diadexus Inc Um novo método de diagnóstico, monitorização, identificação de estágio, imagiologia e tratamento de vários cancros

Also Published As

Publication number Publication date
CA2343918A1 (en) 2000-03-30
EP1115426A1 (de) 2001-07-18
WO2000016805A1 (en) 2000-03-30
ES2267291T3 (es) 2007-03-01
ATE327766T1 (de) 2006-06-15
DE69931644T2 (de) 2007-05-10
JP2002526055A (ja) 2002-08-20
EP1115426B1 (de) 2006-05-31
EP1115426A4 (de) 2002-07-24

Similar Documents

Publication Publication Date Title
ATE413466T1 (de) Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
EP1099102A4 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
EP1363920A4 (de) Modifizierte psma-liganden und deren verwendung
DE69929785D1 (de) Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs
WO2004067570A3 (en) Prostate cancer diagnosis and treatment
DE69510336T2 (de) Verfahren zur diagnose von praeklampsie
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2004021010A3 (en) Method of diagnosing colon and gastric cancers
WO2004021009A3 (en) Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
AU3392901A (en) Proteins
WO2001037779A3 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
DE69931644D1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
NO20014805D0 (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
ATE395600T1 (de) Verfahren zur diagnose von knochenmetastasen aus malignen tumoren
EP1371729A3 (de) Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATA19972000A (de) Pibf für die diagnose von tumoren
WO2000071081A3 (en) Methods of diagnosis and treatment of meniere disease
ATE520031T1 (de) Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee